Report #2830199

Overview

Sex

Female

Age

Age unknown

State

PA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Prescription for Arexvy for patient under 60; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of off label use in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced off label use (Verbatim: Prescription for Arexvy for patient under 60). The outcome of the off label use was not applicable. Additional Information: GSK Receipt Date: 26-FEB-2025 The pharmacist stated that a doctor wanted to administer Arexvy to a special need of patient who was 38 years old, which led to off label. The adverse event report completed as there was an active prescription. The Vaccine Administration Facility is the same as Primary Reporter.